Macugen
Quick Facts
Pegaptanib sodium
Date Approved
December 17, 2004
Manufacturer
Pfizer
Status
4/7/06 label updates
On the market
Approved Uses
Age-related macular degeneration
Serious Side Effects
Blindness
Vision loss
Anaphylaxis
Anaphylactoid
Angioedema
Related Topics
Anaphylactic Shock
Defective Drugs
Diseases
Macugen Side Effects Could Result In Angiodema Lawsuits
Macugen | Lawsuits, Lawyers | Side Effects: Angiodema, Vision Loss, Swelling Around Eyes
Macugen (pegaptanib sodium), manufactured by Eyetech Pharmaceuticals Inc. and Pfizer, Inc., is prescribed to treat adults with an eye problem called the wet form (neovascular) of age-related macular degeneration. Macular degeneration results in vision loss that can lead to blindness. Macugen was granted FDA approval on December 17, 2004. It is administered every six weeks via injection into the eye. On April 7, 2006, Eyetech, Pfizer and the FDA notified ophthalmologic healthcare professionals, surgical service supervisors and other healthcare professionals of important changes in the approved product labeling for Macugen, including changes to the contraindications, precautions, adverse post-marketing events, and dosage and administrations sections on the label.
Macugen Side Effects & Reactions
There have been rare reports of anaphylaxis/anaphylactoid reactions including angioedema following the administration of Macugen along with various medications administered as part of the injection preparation. Angiodema is a reaction that causes swelling around the eyes, lips and often genitals, hands and feet. It is recommended that healthcare professionals evaluate the patient's medical history for hypersensitivity reactions to Macugen prior to prescribing the drug.
About Macular Degeneration
Age-related macular degeneration (AMD) is an eye condition that affects the retina, which is the back part of your eye. The center of the retina contains the macula. The macula allows you to see objects straight ahead, which is called central vision. Macular degeneration damages the macula, which causes you to lose your central vision. Wet AMD results from the growth of abnormal, leaky blood vessels below the retina. Age-related macular degeneration (AMD) occurs in people over 60. Today, at least 15 million people in the United States have this health problem.
Legal Help For Victims Affected By Macugen
If you or a loved one took Macugen and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-LAW-INFO (1-800-529-4636).










